secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harvard Apparatus Regenerative Technology, Inc. (HRGN)
CIK:        0001563665
Form:       8-K/A
Filed at:   2022-09-20T23:59:59+00:00
Accession:  0001104659-22-101343
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Biostage adopts annual say-on-pay votes after stockholder advisory vote
-----------------------------------------------------------------------

- Advisory vote: 7,539,731 shares favored one year, 28,038 three years, 110,760 abstained.
- Board decided to hold future say-on-pay votes annually until next frequency vote (no later than 2028).
- Amendment solely discloses frequency decision; no other changes to original 8-K from June 22, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563665/000110465922101343/0001104659-22-101343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563665/000110465922101343/tm2226229d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-101343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer